logo
logo
AI + EXCLUSIVE DATA

AI identifies M&A opportunities from proprietary sources

Our AI analyzes exclusive acquisition data to predict which merged companies need YOUR integration capabilities.

10-25 M&A leads daily • Tech stack analysis • Integration scoring
Start with:
Flexible Plans • $39/mo or $29/mo annual
AI + exclusive M&A intelligence
Post-merger opportunity analysis
INDUSTRY FIRST

Azurity Pharmaceuticals acquires Covis Pharma

Mar 14, 20255 months ago

Acquiring Company

Azurity Pharmaceuticals

Acquired Company

Covis Pharma

WoburnZugPharmaceuticalMedicalBiotechnologyHealth CareManufacturingHealth Care

Description

Azurity Pharmaceuticals announces the successful completion of its acquisition of Covis Group S.à r.l., now a wholly-owned subsidiary. This strategic acquisition enhances Azurity's leadership in branded pharmaceuticals and aims to better serve overlooked patients globally. The collaboration is expected to leverage the strengths of both organizations to accelerate drug development.

Company Information

Company

Azurity Pharmaceuticals

Location

Woburn, Massachusetts, United States

About

Azurity is a privately-held pharmaceutical company specializing in providing innovative, high-quality medicines that serve overlooked patients. Azurity supplies a large number of products to treat a wide range of medical conditions. These include cardiovascular, central nervous system, endocrine, gastro-intestinal, anti-infective and oncology medicines. Many of Azurity's medicines are dose-form innovations for patients with needs that are not met by other available products. Azurity's medicines have benefited millions of people.

FundzWatch™ Score

64
High M&A Activity

Related People

Sign in to view contact details

Sign in to view contact details

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed